Tuesday December 11, 2018
Home India Sketch by a 1...

Sketch by a 10-Year-Old Girl Victim in Delhi Sends her Rapist Uncle to Jail

Delhi court judge Vinod Yadav gave a verdict in girls' favor

0
//
Rapist was convicted based on this sketch
Rapist was convicted based on this sketch.
Republish
Reprint

New Delhi, August 27, 2017: Based on a pencil sketch of a 10-year-old child victim, Delhi court judge Vinod Yadav has taken the decision to punish her 45-year-old uncle for rape and sentenced him to 5 years in jail on June 2016.

Her uncle Akhter Ahmed, who has been jailed for sexual assault, said that the girl had been tortured to speak against him in the court. He also said that she is not a competent witness but the sketch she drew to keep herself busy during trial proceedings, made the Judge to put the rapist behind bars.

The judge gave the verdict based on, “A close scrutiny of the drawing reveals that she has depicted an abandoned house in gloomy colors, a girl carrying some balloons with intermingled threads and her dress lying removed.” The Additional Sessions Judge Vinod Yadav said that the sketch highlighted the lasting torturous impression of the sexual assault that is left on her the mind and this ruled what the uncle earlier said of her not being competent to testify against him.

ALSO READ: Serial rapist has killed over 30 children: police

The girl’s horrifying incidence which is like a nightmare had its origin in the year 2014, the time when she moved in with her aunt from Kolkata to Delhi. Her mother died and her father (who was a drug addict) abandoned her. This is also the year when her trauma started.

Her uncle used to sexually abuse her. The little girl tried to confide in her aunt, wanted to tell her what happened with her but she thought her aunt wouldn’t listen to her. So, one day, she just ran out of the home so as to escape the torture she was dealing with. A conductor saw her on a bus in November 2014, she was sitting all alone and crying. He tried to talk to her and find out what is wrong but she didn’t say a word. Thus, he handed her over to the police, who called in the counselors for help from a non-governmental organization (NGO) called Haq Foundation.

According to NDTV report, the girl’s counselor Uzma Pravin told, “For the first few sessions the girl was not revealing what was going on in her mind but as she became more familiar, she started opening up in bits and pieces.” Uzma joined the puzzle pieces of information together and started to shape up the young girl’s narrative until she was more coherent.

But when the counselors gave her a sheet of paper, pencil, and crayons during the proceedings of the court, they thought it was a way to help the child stay busy with something and would feel less nervous about what was going on. But, one day when the young girl showed the sketch she made to the counselor Uzma Pravin, she gave it to the judge.

She said, “Her drawings revealed a lot about her. There was always something in it. Most children can’t express themselves. However, if we try to look at their drawings, we can understand them,” mentions NDTV report.

Her colleague, Bharti Ali, said that drawing therapy was one of the child-friendly practices which the Chief Justice of Delhi High Court, Gita Mittal encouraged foundations like Haq to undertake  Bharti Ali said that the court verdict was a kind of positive development and a moment of victory but she hoped that more judges in future could use and allow innovative methods like this.


NewsGram is a Chicago-based non-profit media organization. We depend upon support from our readers to maintain our objective reporting. Show your support by Donating to NewsGram. Donations to NewsGram are tax-exempt.
Click here- www.newsgram.com/donate

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Congo Start Trials For Drugs Against Ebola

This is Congo's tenth outbreak since the virus was identified there in 1976.

0
Congo
Congolese and WHO officials prepare equipment before the launch of vaccination campaign against the deadly Ebola virus near Mangina village, DRC, Aug. 8, 2018. Congo has now begun the first-ever trial to test the effectiveness and safety of four experimental Ebola drugs. VOA

Congo has begun the first-ever trial to test the effectiveness and safety of four experimental Ebola drugs, the first time scientists have directly compared such treatments, the World Health Organization said Monday.

The U.N. health agency described the multi-drug trial as “a giant step” that would “bring clarity about what works best.”

“While our focus remains on bringing this outbreak to an end, the launch of the randomized control trial in DRC [Congo] is an important step toward finally finding an Ebola treatment that will save lives,” said WHO Director-General Tedros Adhanom Ghebreyesus.

Congo
Dr. Tedros Adhanom Ghebreyesus, WHO director-general, center, speaks to a health official at a newly established Ebola response center in Beni, Democratic Republic of Congo. VOA
Since the beginning of the Ebola outbreak in the North Kivu province in August, four therapeutic drugs have been used to treat patients, namely mAb 114, ZMapp, Remdesivir and Regeneron, according to Congo’s Health Ministry.

To date, more than 160 people have been treated with these experimental drugs. Patients won’t be treated much differently than before, but scientists will now have a clinical trial framework to collect data on the three antibody treatments and the antiviral.

Congo’s Health Ministry said the clinical trial began last week in Beni with Zmapp, mAb 114 and Remdesivir. The test could be extended to other sites and include the fourth medicine, it said. The number of patients who participate “will depend on the evolution of the epidemic and the willingness of patients to participate.”

Congo, Uganda, ebola
A Congolese health worker administers Ebola vaccine to a boy who had contact with an Ebola sufferer in the village of Mangina in North Kivu province of the Democratic Republic of the Congo. VOA

Congo, with poor infrastructure, presents a difficult environment for administering these treatments. ZMapp is difficult to use; it takes three infusions, given over hours. If patients are treated with Remdesivir, their liver function must be analyzed regularly.

Because the data collected in the North Kivu epidemic is unlikely to be sufficient for a complete study, the ministry said that the clinical trial may extend over a five-year period to cover several Ebola outbreaks in several countries.

So far in the current outbreak in Congo, there have been 365 confirmed Ebola cases with 189 deaths, according to figures provided by the health ministry Sunday.

Congo
– Dr. Oly Ilunga Kalenga, minister of health of the Democratic Republic of Congo, addresses residents at the town all of Mbandaka, May 21, 2018, during the launch of the Ebola vaccination campaign. VOA
“Our country is struck with Ebola outbreaks too often, which also means we have unique expertise in combatting it,” said Congo’s Minister of Health Dr. Oly Ilunga Kalenga. “These trials will contribute to building that knowledge, while we continue to respond on every front to bring the current outbreak to an end.”
Also Read: WHO Ships Vaccination For Yellow Fever in Ethiopia

This is Congo’s tenth outbreak since the virus was identified there in 1976. The outbreak has been plagued by security problems, with health workers attacked by rebels in districts where the virus has been spreading. (VOA)